408 related articles for article (PubMed ID: 17533052)
21. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
Pearson S; Sroczynska P; Lacaud G; Kouskoff V
Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
[TBL] [Abstract][Full Text] [Related]
22. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
23. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
24. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
25. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
26. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
27. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
28. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
29. Pathways in blood and vessel development revealed through zebrafish genetics.
Crosier PS; Kalev-Zylinska ML; Hall CJ; Flores MV; Horsfield JA; Crosier KE
Int J Dev Biol; 2002; 46(4):493-502. PubMed ID: 12141436
[TBL] [Abstract][Full Text] [Related]
30. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
31. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
32. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
[TBL] [Abstract][Full Text] [Related]
33. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins.
Lou J; Cao W; Bernardin F; Ayyanathan K; RauscherIII FJ; Friedman AD
Oncogene; 2000 May; 19(22):2695-703. PubMed ID: 10851069
[TBL] [Abstract][Full Text] [Related]
34. Upstream and downstream targets of RUNX proteins.
Otto F; Lübbert M; Stock M
J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
[TBL] [Abstract][Full Text] [Related]
35. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
36. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
37. ETO-2, a new member of the ETO-family of nuclear proteins.
Davis JN; Williams BJ; Herron JT; Galiano FJ; Meyers S
Oncogene; 1999 Feb; 18(6):1375-83. PubMed ID: 10022820
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation.
Bae SC; Lee YH
Gene; 2006 Jan; 366(1):58-66. PubMed ID: 16325352
[TBL] [Abstract][Full Text] [Related]
39. Mesodermal patterning activity of SCL.
Ismailoglu I; Yeamans G; Daley GQ; Perlingeiro RC; Kyba M
Exp Hematol; 2008 Dec; 36(12):1593-603. PubMed ID: 18809240
[TBL] [Abstract][Full Text] [Related]
40. RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells.
Robert-Moreno A; Espinosa L; de la Pompa JL; Bigas A
Development; 2005 Mar; 132(5):1117-26. PubMed ID: 15689374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
